Beauty Health (SKIN) Expected to Release Earnings on Thursday

Beauty Health (NASDAQ:SKIN) is projected to announce its Q2 2026 results after the market closes on Thursday, August 6th. Analysts expect the company to post earnings of ($0.04) per share and revenue of $74.45 million for the quarter. Investors may review the information on the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Thursday, August 6, 2026 at 4:30 PM ET.

Beauty Health (NASDAQ:SKIN) last posted its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.09) by $0.04. Beauty Health had a negative return on equity of 9.38% and a negative net margin of 2.03%.The firm had revenue of $64.91 million during the quarter, compared to analysts’ expectations of $66.28 million. On average, analysts expect Beauty Health to post $-0 EPS for the current fiscal year and $-0 EPS for the next fiscal year.

Beauty Health Price Performance

Shares of NASDAQ:SKIN opened at $0.71 on Wednesday. Beauty Health has a 1-year low of $0.55 and a 1-year high of $2.69. The firm has a market capitalization of $91.42 million, a PE ratio of -4.15 and a beta of 1.07. The business’s 50 day moving average is $0.73 and its 200-day moving average is $0.93. The company has a current ratio of 1.79, a quick ratio of 1.48 and a debt-to-equity ratio of 4.37.

Hedge Funds Weigh In On Beauty Health

Hedge funds have recently modified their holdings of the stock. Woodline Partners LP boosted its stake in Beauty Health by 255.9% in the 3rd quarter. Woodline Partners LP now owns 5,930,027 shares of the company’s stock valued at $11,801,000 after buying an additional 4,263,997 shares in the last quarter. Millennium Management LLC grew its position in Beauty Health by 127.0% in the fourth quarter. Millennium Management LLC now owns 5,764,802 shares of the company’s stock valued at $8,013,000 after acquiring an additional 3,225,668 shares during the period. Geode Capital Management LLC raised its stake in Beauty Health by 27.5% during the second quarter. Geode Capital Management LLC now owns 2,302,784 shares of the company’s stock worth $4,399,000 after acquiring an additional 496,963 shares in the last quarter. State Street Corp raised its stake in Beauty Health by 0.9% during the fourth quarter. State Street Corp now owns 1,871,527 shares of the company’s stock worth $2,601,000 after acquiring an additional 16,493 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. lifted its holdings in shares of Beauty Health by 11.8% during the third quarter. Jacobs Levy Equity Management Inc. now owns 1,210,898 shares of the company’s stock valued at $2,410,000 after acquiring an additional 127,994 shares during the period. 93.26% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

SKIN has been the subject of a number of recent research reports. Zacks Research lowered Beauty Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 20th. Roth Capital reiterated a “buy” rating and set a $2.00 price target (down from $2.50) on shares of Beauty Health in a research note on Wednesday, May 20th. Canaccord Genuity Group lowered their price target on shares of Beauty Health from $1.50 to $1.00 and set a “hold” rating on the stock in a report on Friday, May 1st. Finally, Weiss Ratings cut shares of Beauty Health from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, July 23rd. One equities research analyst has rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $1.52.

Beauty Health Company Profile

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.